Thank you. Merci.
I want to wrap up with a couple of questions.
What we hear, certainly in Ottawa and across the country, is that in terms of basic research over the last 11 years, the actions taken by the federal and provincial governments have, in the view of the research community in Canada, reversed a lot of the brain drain. From a basic research point of view, they say that Canada is doing fairly well, just to be very basic, but that from a commercialization point of view we're not doing well. That's certainly what we heard from the panel yesterday in Manitoba.
As a committee, one of the things we're looking for is examples of success: why did they succeed and how do we emulate that success?
To Mr. Hodgson, I've toured VIDO before. Unfortunately, we didn't have time to tour it today. You talked about commercialization successes; vaccine products have been talked about. Can you highlight for the committee why these successes happened? Were there commonalities you can point to there to say that these are some factors involved, that these are things we should emulate, and that these are some policies we as a committee should consider altering?
Can you talk about your successes and how they were actually achieved?